Laura Woods is committed to patient safety issues. She enjoys breaking news about FDA recalls, sharing important events in pharmaceutical litigation, and reporting on favorable outcomes for victims of dangerous drugs and medical devices.
A generic Lipitor recall has been issued by India’s largest drugmaker, Ranbaxy Laboratories, Ltd. More than 64,000 bottles of the generic cholesterol-lowering drug have been recalled, following regulatory concerns on the manufacturing quality of the drug, after a dosage error was identified. According to the... Read More
A Georgia woman and her husband have filed a da Vinci surgical system lawsuit, after she sustained life-threatening injuries following a hysterectomy. She was forced to undergo invasive emergency surgery to correct these complications. The plaintiffs allege the injuries were caused by the da Vinci... Read More
A West Virginia federal judge has denied summary judgment to Boston Scientific in a pelvic mesh device lawsuit, finding an issue of fact regarding whether the plaintiff could have realized a connection between her injuries and the product within the two-year statute of limitations. On... Read More
Results of a recent study have revealed that metal-on-metal hip replacement failure rates are two-to-three times higher than in other types of artificial implants. In the January issue of the Journal of Bone and Joint Surgery, the American Association of Hip and Knee Surgeons, the... Read More
A new study published last month in the British Journal of Medicine suggests that nearly 25% of all artificial hip implants do not receive proper testing prior to hitting the market. According to researchers from the U.K., many hip implant systems receive approval for patient... Read More
At least four Stryker Rejuvenate hip lawsuits have been settled as a result of early mediation efforts. Stryker’s parent company, Howmedica Osteonics Corp., currently faces around 1,000 complaints regarding issues with their Rejuvenate and ABG II hip implants, but that number is expected to grow. While... Read More
The U.S. District Judge presiding over the group of Zoloft birth defect lawsuits currently pending under multidistrict litigation in the Eastern District of Pennsylvania has outlined the process of narrowing down the lawsuits eligible for the first bellwether trials. More than 420 product liability cases... Read More
Boehringer Ingelheim Pharmaceuticals Inc. (BIPI), was fined nearly $1 million for discovery abuse in Pradaxa multidistrict litigation, currently pending in Illinois. U.S. District Judge David R. Herndon, who is overseeing the MDL, said BIPI failing to produce thousands of documents resulted in bad-faith conduct. BIPI,... Read More
